sellas life sciences group stock
SLS stock analyst estimates including earnings and revenue EPS upgrades and downgrades. As of 1116am ET.
Client Name Sellas Life Sciences Url Www Sellaslifesciences Com Industry Biopharmaceuticals Site Type Corporate Design Type Life Science Science Life
SLS across all therapeutic and diagnostic uses worldwide outside of Greater China mainland China Hong Kong.
. RT Quote NASDAQ USD. News SELLAS Life Sciences Group Inc. 7 Times Square Suite 2503 New York NY 10036 646-200-5278.
The price has been going up and down for this period and there has been a -149 loss for the last 2 weeks. SELLAS Life Sciences Group Inc. 01 4 Comments Sellas Life Sciences licenses CDK9 inhibitor from Chinas GenFleet Therapeutics SA NewsThu Mar.
About SELLAS Life Sciences Group Inc. 350000000 shares authorized 15905999 and 15895637 shares issued and outstanding at March 31 2022 and. SELLAS LIFE SCIENCES GROUP INC.
SLS is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. Common Stock SLS Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. 23 hours agoEach common stock warrant sold with the shares of common stock represents the right to purchase one share of our common stock at an exercise price of 540 per share.
SLS is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. SELLAS Life Sciences Stock Plunges After 25M Capital Raise Via Equity In-Licenses Cancer-Focused CDK9 Inhibitor GenFleet Therapeutics has granted GFH009 rights to SELLAS Life Sciences Group Inc NASDAQ. Sellas Life Sciences Group Inc.
Analyst Recommendations on SELLAS LIFE SCIENCES GROUP INC. BATS BZX Real-Time Price. See SELLAS Life Sciences Group Inc.
Δ 5 Yr. SELLAS Life Sciences Group Inc. SELLAS Life Sciences Newly Licensed GFH009 Asset Shows Significant Anti-Leukemic Effect in Acute Myeloid Leukemia Patients RelapsedRefractory to Venetoclax in Ongoing Phase 1 Study.
During the day the stock fluctuated 714 from a day low at 252 to a day high of 270. Common stock 00001 par value. Last 050622 EDT.
Alliance Global Adjusts Price Target on SELLAS Life Sciences Group to 14 From 1650. Learn about SELLAS Life Sciences Group Inc SLSXNAS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and other stock. 350000000 shares authorized 15905999 and 15895637 shares issued and.
Contact United States Of America. Compare SLS Stock to Peers. Get the latest Sellas Life Sciences Group Inc SLS real-time quote historical performance charts and other financial information to help you make more.
Stock price fell by -375 on the last day Friday 6th May 2022 from 267 to 257. Common stock 00001 par value. About SELLAS Life Sciences Group.
SELLAS Life Sciences plunged 24 on 25M stock offering SA NewsFri Apr. Find the latest SEC Filings data for SELLAS Life Sciences Group Inc. Δ 1 Yr.
SELLAS Life Sciences Group Inc. Maxim Group Thinks SELLAS Life Sciences Groups Stock is Going to Recover. SELLAS Life Sciences Group Inc.
RXK3F stock quote history news and other vital information to help you with your stock trading and investing. The SELLAS Life Sciences Group Inc. And has now fallen 3 days in a row.
Key Stock Data PE Ratio TTM NA EPS TTM -132 Market Cap 5278 M Shares Outstanding 1589 M Public. CONSOLIDATED STATEMENTS OF OPERATIONS Amounts in thousands except share and per share data Unaudited Three Months Ended March 31 2022. Is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications.
The Companys lead product candidate galinpepimut-S GPS is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center. Find the latest SELLAS Life Sciences Group Inc. No significant news for SLS in the past two years.
3 weeks ago - Benzinga. Sellas Life Sciences Group Inc NASDAQSLS Sellas Life Sciences Group Inc. 20 rows SELLAS Life Sciences Group Inc Registered Shs Stock SLS 286 001 035 Official Close.
Pin On Information Is Wealth